Cochlear Limited (COH.AX)
| Previous close | 318.24 |
| Open | 315.01 |
| Bid | 315.33 x 10000 |
| Ask | 320.00 x 3400 |
| Day's range | 315.01 - 320.99 |
| 52-week range | 220.40 - 350.17 |
| Volume | |
| Avg. volume | 146,696 |
| Market cap | 20.885B |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | 60.05 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 4.00 (1.26%) |
| Ex-dividend date | 21 Mar 2024 |
| 1y target est | N/A |
- PR Newswire
Cochlear calls for action in Washington D.C. ahead of World Hearing Day
Today, Cochlear assembled a team of hearing experts to emphasize the importance of hearing health for policy makers at the Australian Embassy in Washington D.C. ahead of World Hearing Day on Sunday March 3rd.
- PR Newswire
Cochlear announces 2024 winners of annual scholarships
Eight outstanding Cochlear™ Nucleus® Implant, Cochlear Baha® System and Cochlear Osia® System recipients have been announced as the winners of the 2024 annual Cochlear Academic Scholarships. From founding nonprofit organizations to performing in musicals, to telling underrepresented stories through visual art, and much more, each of the recipients have extraordinary stories on top of their perseverance through hearing loss.
- PR Newswire
Cochlear and TechSee Win Silver in the 13th Annual Best in Biz Awards 2023
TechSee is excited to announce their customer, Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, has been named a silver winner in the Most Innovative Product of the Year - Healthcare category in Best in Biz Awards, the only independent business awards program judged each year by prominent editors and reporters from top-tier publications in North America for use of TechSee's technology.
